Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
117 hedge funds and large institutions have $165M invested in Gritstone bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 25 closing their positions.
2% more funds holding
Funds holding: 115 → 117 (+2)
9% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 35
8% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 25
27% less call options, than puts
Call options by funds: $1.57M | Put options by funds: $2.16M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
74% less capital invested
Capital invested by funds: $630M → $165M (-$465M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$18.2M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$6.43M |
| 3 |
Millennium Management
New York
|
+$3.19M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.67M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$77.3M |
| 2 |
FM
Frazier Management
Seattle,
Washington
|
-$60M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$20.2M |
| 4 |
State Street
Boston,
Massachusetts
|
-$14.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.2M |
GRTS Hedge Fund Activity: Q1 2022 in Review
117 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q1 2022, worth a combined $165M — down 74% from $630M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new GRTS positions and 25 closed out — a net gain of 2 holders — while 38 added to existing stakes and 35 trimmed.
The largest buyer was Redmile Group, adding an estimated $18.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $77.3M sold.
- 117 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q1 2022, up from 115 in Q4 2021.
- Funds reported $165M of Gritstone bio, Inc. Common Stock stock for Q1 2022, down 74% quarter-over-quarter.
- 27 funds opened new Gritstone bio, Inc. Common Stock positions in Q1 2022 and 25 closed out, a net change of +2 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q1 2022 was Redmile Group, an estimated $18.2M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q1 2022 was EcoR1 Capital, an estimated $77.3M sold.
Based on aggregated 13F filings for Q1 2022.